➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Baxter
Dow
Boehringer Ingelheim
Medtronic

Last Updated: July 10, 2020

DrugPatentWatch Database Preview

Neurocrine Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for Neurocrine
International Patents:134
US Patents:12
Tradenames:2
Ingredients:2
NDAs:2

Drugs and US Patents for Neurocrine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Neurocrine INGREZZA valbenazine tosylate CAPSULE;ORAL 209241-001 Apr 11, 2017 RX Yes No   Start Trial   Start Trial
Neurocrine ONGENTYS opicapone CAPSULE;ORAL 212489-001 Apr 24, 2020 RX Yes No 10,583,130   Start Trial   Start Trial
Neurocrine ONGENTYS opicapone CAPSULE;ORAL 212489-002 Apr 24, 2020 RX Yes Yes 9,745,290   Start Trial Y   Start Trial
Neurocrine ONGENTYS opicapone CAPSULE;ORAL 212489-002 Apr 24, 2020 RX Yes Yes 8,524,746   Start Trial   Start Trial
Neurocrine ONGENTYS opicapone CAPSULE;ORAL 212489-001 Apr 24, 2020 RX Yes No 9,630,955   Start Trial Y Y   Start Trial
Neurocrine ONGENTYS opicapone CAPSULE;ORAL 212489-001 Apr 24, 2020 RX Yes No 8,168,793   Start Trial Y Y   Start Trial
Neurocrine ONGENTYS opicapone CAPSULE;ORAL 212489-001 Apr 24, 2020 RX Yes No 10,357,468   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for Neurocrine Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1907382 CA 2016 00061 Denmark   Start Trial PRODUCT NAME: OPICAPONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/15/1066 20160628
1907382 57/2016 Austria   Start Trial PRODUCT NAME: OPICAPON ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1066 (MITTEILUNG) 20160628
1907382 CR 2016 00061 Denmark   Start Trial PRODUCT NAME: OPICAPONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/15/1066 20160628
2481410 C02481410/01 Switzerland   Start Trial PRODUCT NAME: OPICAPON; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66547 26.04.2018
1907382 16C1016 France   Start Trial PRODUCT NAME: OPICAPONE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE; REGISTRATION NO/DATE: EU/1/15/1066 20160628
1907382 PA2016036,C1907382 Lithuania   Start Trial PRODUCT NAME: OPIKAPONAS ARBA JO FARMACINIU POZIURIU PRIIMTINOS DRUSKOS; REGISTRATION NO/DATE: EU/1/15/1066 20160624
1907382 1690058-1 Sweden   Start Trial PRODUCT NAME: OPICAPONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/15/1066 20160628
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Johnson and Johnson
AstraZeneca
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.